Literature DB >> 33395554

Bayesian Statistics for Surgical Decision Making.

Gabrielle E Hatton1,2,3, Claudia Pedroza4, Lillian S Kao1,2,4,3.   

Abstract

Background: Application of clinical study findings to surgical decision making requires accurate interpretation of the results, integration of the findings within the context of pre-existing knowledge and use of statistics to answer clinically relevant questions. Bayesian analyses are optimally suited for interpretation of study findings, supporting translation to the bedside. Discussion: Surgical decision making is a complex process that draws on an individual clinician's medical knowledge, experience, data, and the patient's unique characteristics and preferences. Subjective and objective knowledge may be merged to derive a probability of benefit or harm of a treatment under consideration. Bayesian reasoning complements the clinical decision-making process by incorporating known evidence and data from a new study to determine the probability of an outcome of interest. Bayesian analyses are statistically robust and intuitive when translating findings of a study into clinical care. In contrast, frequentist statistics are poorly suited to translate study findings to clinical application. This review aims to highlight the benefits of incorporating Bayesian analyses into clinical research.
Conclusion: Bayesian analyses offer clinically relevant information including the probability of benefit or harm of a treatment under consideration while accounting for uncertainty. This information may be incorporated easily and accurately into surgical decision making.

Entities:  

Keywords:  Bayesian statistics; decision making; likelihood; posterior probability; prior probability

Mesh:

Year:  2020        PMID: 33395554      PMCID: PMC8420942          DOI: 10.1089/sur.2020.391

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   1.853


  17 in total

Review 1.  Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system.

Authors:  P Royle; N Waugh
Journal:  Health Technol Assess       Date:  2003       Impact factor: 4.014

Review 2.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.

Authors:  Dirk Bassler; Matthias Briel; Victor M Montori; Melanie Lane; Paul Glasziou; Qi Zhou; Diane Heels-Ansdell; Stephen D Walter; Gordon H Guyatt; David N Flynn; Mohamed B Elamin; Mohammad Hassan Murad; Nisrin O Abu Elnour; Julianna F Lampropulos; Amit Sood; Rebecca J Mullan; Patricia J Erwin; Clare R Bankhead; Rafael Perera; Carolina Ruiz Culebro; John J You; Sohail M Mulla; Jagdeep Kaur; Kara A Nerenberg; Holger Schünemann; Deborah J Cook; Kristina Lutz; Christine M Ribic; Noah Vale; German Malaga; Elie A Akl; Ignacio Ferreira-Gonzalez; Pablo Alonso-Coello; Gerard Urrutia; Regina Kunz; Heiner C Bucher; Alain J Nordmann; Heike Raatz; Suzana Alves da Silva; Fabio Tuche; Brigitte Strahm; Benjamin Djulbegovic; Neill K J Adhikari; Edward J Mills; Femida Gwadry-Sridhar; Haresh Kirpalani; Heloisa P Soares; Paul J Karanicolas; Karen E A Burns; Per Olav Vandvik; Fernando Coto-Yglesias; Pedro Paulo M Chrispim; Tim Ramsay
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

3.  Assessing whether to perform a confirmatory randomized clinical trial.

Authors:  M K Parmar; R S Ungerleider; R Simon
Journal:  J Natl Cancer Inst       Date:  1996-11-20       Impact factor: 13.506

Review 4.  Publication bias in clinical trials due to statistical significance or direction of trial results.

Authors:  Sally Hopewell; Kirsty Loudon; Mike J Clarke; Andrew D Oxman; Kay Dickersin
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

5.  Problem with p values: why p values do not tell you if your treatment is likely to work.

Authors:  Robert Price; Rob Bethune; Lisa Massey
Journal:  Postgrad Med J       Date:  2019-10-29       Impact factor: 2.401

6.  When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.

Authors:  J C Sinclair; R J Cook; G H Guyatt; S G Pauker; D J Cook
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

7.  A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty.

Authors:  Alexander J Sutton; Nicola J Cooper; Keith R Abrams; Paul C Lambert; David R Jones
Journal:  J Clin Epidemiol       Date:  2005-01       Impact factor: 6.437

Review 8.  Artificial Intelligence and Surgical Decision-making.

Authors:  Tyler J Loftus; Patrick J Tighe; Amanda C Filiberto; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Parisa Rashidi; Gilbert R Upchurch; Azra Bihorac
Journal:  JAMA Surg       Date:  2020-02-01       Impact factor: 14.766

Review 9.  Which resources should be used to identify RCT/CCTs for systematic reviews: a systematic review.

Authors:  Ellen T Crumley; Natasha Wiebe; Kristie Cramer; Terry P Klassen; Lisa Hartling
Journal:  BMC Med Res Methodol       Date:  2005-08-10       Impact factor: 4.615

10.  Elicitation of prior probability distributions for a proposed Bayesian randomized clinical trial of whole blood for trauma resuscitation.

Authors:  Jan O Jansen; Henry Wang; John B Holcomb; John A Harvin; Joshua Richman; Elenir Avritscher; Shannon W Stephens; Van Thi Thanh Truong; Marisa B Marques; Stacia M DeSantis; Jose-Miguel Yamal; Claudia Pedroza
Journal:  Transfusion       Date:  2020-01-22       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.